LOGO VASCULITIS fecha
BANNER GESCO 128kb

@VasculitisBCN24

Topics for discussion


Clinical and translational aspects of vasculitis and related diseases addressed to a multidisciplinary audience (rheumatologists, nephrologists, general internists, dermatologists, immunologists, neurologists, pulmonologists, pediatricians, otorhinolaryngologists and basic scientists interested in vasculitis):

  1. CLINICAL SCIENCE
  • 1.1  Diagnosis and classification: imaging (role in diagnosis, new tracers); pathology...
  • 1.2  Treatment: clinical trials (new trials, post-hoc analysis, long-term follow-up); real world data with new therapies; observational studies; emerging therapies (i.e. CAR-T, multi-target molecules); classical and new treatment optimization for special situations (frailty, advanced age…)…
  • 1.3  Specialized management of specific situations: subglottic stenosis, vascular reconstruction and endovascular intervention, renal transplantation, cutaneous necrotic lesions, pregnancy...
  • 1.4  Disease Assessment: activity, damage, response and remission criteria, imaging...
  • 1.5  Outcomes: remission, relapse, mortality, patient reported outcomes...
  • 1.6  End-organ damage: kidney failure, pulmonary and cardiac fibrosis...
  • 1.7  Comorbidities: cardiovascular risk, frailty, osteoporosis, infection and its prevention, vaccines...
  • 1.8  Pediatric vasculitis
  • 1.9  Rare forms of vasculitis
  • 1.10  Vasculitis -related diseases: polymyalgia rheumatica, IgG4-related disease…
  • 1.11  Infectious vasculitis, vasculitis associated to autoimmune or haematologic disorders.
  1. TRANSLATIONAL SCIENCE
  • 2.1  Genetics and epigenetics. Alterations leading to monogenic vasculitis
  • 2.2  Exposome: climate, pollutants, triggering infectious agents...
  • 2.3  Cellular and molecular mechanisms of disease:  B cells, T cells, macrophages, eosinophils, neutrophils, endothelial cells, stromal cells, complement, senescent cells...
  • 2.4  Mechanisms of tissue injury: oxidative damage, proteases, apoptosis, extracellular traps…
  • 2.5  Mechanisms of tissue repair: vascular remodelling, fibrosis…
  • 2.6  Biomarkers: diagnosis, prognosis, disease activity, predictors of response...
  • 2.7  Emerging technologies and approaches: organoids, single cell RNA sequencing, spatial transcriptomics, data linkage and machine learning, personalized medicine...
  1. CASE SERIES OR CASE REPORTS OF SPECIAL INTEREST

Important Dates


  • Registration open:
    5th September 2023
  • End of Early Bird Registration:
    15th January 2024
  • Call for abstracts open:
    15th  September 2023
  • Abstract submission deadline:
    4th December 2023
    extended until December 18th
  • Notification of Acceptance:
    20th December 2023
  • Notification of Presentation Type:
    8th February 2024

TECHNICAL SECRETARIAT

C/ Marià Cubí, 4 - Pral | 08006 Barcelona
Tel. +34 932.388.777 | Fax: +34 932.387.488
This email address is being protected from spambots. You need JavaScript enabled to view it.

ORGANIZED BY

079600e51becb8a248f111a209631dbd20798ded

  • Last Update: Friday 01 March 2024, 11:42:21.